Free tool
FAERS Monitor: Zoloft
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019839 or its brand name (Zoloft, Sertraline Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
106,461
Serious
67,510
63% of reports
Hospitalization
30,033
Death reported
7,543
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea7,583
- fatigue7,146
- drug ineffective6,961
- headache6,380
- anxiety5,948
- depression5,895
- pain5,248
- diarrhoea5,226
- dizziness5,121
- dyspnoea4,629
- insomnia4,136
- vomiting4,129
- off label use3,920
- asthenia3,916
- fall3,915
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3,246 |
| 2005 | 3,227 |
| 2006 | 2,879 |
| 2007 | 2,463 |
| 2008 | 2,089 |
| 2009 | 2,791 |
| 2010 | 5,405 |
| 2011 | 6,158 |
| 2012 | 7,062 |
| 2013 | 4,978 |
| 2014 | 4,537 |
| 2015 | 6,116 |
| 2016 | 6,178 |
| 2017 | 5,666 |
| 2018 | 5,359 |
| 2019 | 5,166 |
| 2020 | 4,843 |
| 2021 | 4,310 |
| 2022 | 5,429 |
| 2023 | 4,539 |
| 2024 | 4,772 |
| 2025 | 5,160 |
| 2026 | 4,083 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,947,698 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| depressionSignal | 5,895 | 5.2 | 5.1 | 19,846 |
| anxietySignal | 5,948 | 4.2 | 4.1 | 14,367 |
| insomniaSignal | 4,136 | 3.1 | 3.0 | 5,867 |
| fallSignal | 3,915 | 2.3 | 2.3 | 3,014 |
| astheniaSignal | 3,916 | 2.1 | 2.0 | 2,177 |
| dizzinessSignal | 5,121 | 2.0 | 2.0 | 2,748 |
| headacheSignal | 6,380 | 2.0 | 2.0 | 3,356 |
| nausea | 7,583 | 1.9 | 1.9 | 3,335 |
| fatigue | 7,146 | 1.8 | 1.8 | 2,720 |
| vomiting | 4,129 | 1.7 | 1.7 | 1,321 |
| pain | 5,248 | 1.7 | 1.6 | 1,522 |
| dyspnoea | 4,629 | 1.6 | 1.6 | 1,121 |
| diarrhoea | 5,226 | 1.6 | 1.6 | 1,217 |
| drug ineffective | 6,961 | 1.0 | 1.0 | 13 |
| off label use | 3,920 | 0.9 | 0.9 | 62 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.